Ownership signal CIK-linked ownership evidence from parsed SEC filings. 2 signals
Large-stake signal

Form

SCHEDULE 13D/A

Active or control-oriented beneficial ownership filing.

Ownership

6.5%

Beneficial ownership of this reported class.

Shares

8,335,116 shares

Shares beneficially owned as disclosed.

Event date

25 Apr 2025

Date tied to the ownership event or amendment.

Accepted by SEC

29 Apr 2025

EDGAR acceptance date.

How to read this large-stake filing
  • Schedule 13D/G filings focus on beneficial ownership stakes, not a full portfolio.
  • Compare this filing with the holder history and issuer page before treating the percentage as a current position.
  • Use amendments to understand whether the disclosed stake increased, decreased, or changed reporting status.
Subject security Names, identifiers, and filing context for this profile. 2 source fields
Symbol
ABSI
Shares outstanding
128,232,554 shares
Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
SCHEDULE 13D/A
Accepted by SEC
29 Apr 2025, 21:31:04 UTC
Event date
25 Apr 2025
Next SEC filing
26 Mar 2026
Source filing
View source filing

Key filing fact

Redmile Group, LLC disclosed 6.5% ownership in Absci Corporation Common Stock, $0.0001 par value per share (ABSI) on 25 Apr 2025.

Key facts

  • Redmile Group, LLC filed SCHEDULE 13D/A for Absci Corporation Common Stock, $0.0001 par value per share (ABSI).
  • Disclosed ownership: 6.5%.
  • Date of event: 25 Apr 2025.

Change

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 29 Apr 2025, 21:31.

Research use

  • This page turns one Schedule 13D/G filing into a quick large-stake read before the raw reporting-person rows.
  • Use the linked SEC filing as the source of truth for ownership percentages, shares, and reporting-party details.

Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

View source filing

Reporting persons

Disclosed reporting parties (3)

Names, ownership percentages, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.

Name Ownership Shares owned Sole voting power Shared voting power Signature Title CIK
Redmile Group, LLC 6.5% 8,335,116 0 8,335,116 /s/ Jeremy C. Green Managing Member 0001425738
Jeremy C. Green 6.5% 8,335,116 0 8,335,116 /s/ Jeremy C. Green Jeremy C. Green 0001650527
Redmile Biopharma Investments II, L.P. 4.9% 6,267,205 0 6,267,205 /s/ Jeremy C. Green Managing Member of Redmile Biopharma Investments II (GP), LLC, general partner of Redmile Biopharma Investments II, L.P. 0001772230
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .